Science News
about Depression
Find
Press Releases and Science Updates
by Topic
- Medication and Psychotherapy Treat Depression in Low-Income Minority Women
-
July 1, 2003
Press Release
Treatment with medication or psychotherapy reduced depressive symptoms in women from minority populations, according to research funded by the National Institute of Mental Health (NIMH).
- NIMH Awards $22.6 Million for Center for Collaborative Research on Mental Disorders
-
July 1, 2003
Press Release
Under a cooperative agreement, the Center will accelerate progress toward understanding genetic origins of mental disorders including autism, schizophrenia, bipolar disorder, and depression.
- NIMH Launches First Public Health Education Campaign To Reach Men With Depression
-
April 1, 2003
Press Release
The National Institute of Mental Health (NIMH), one of the National Institutes of Health, today announced the launch of the first national campaign to raise awareness that depression is a major public health problem affecting an estimated 6 million men annually.
- Treatment for Minor Depression
-
March 21, 2003
Press Release
In a new approach to research on minor depression, the National Institutes of Health (NIH) has launched a four-year study to determine the safety and effectiveness of St. John’s wort, a common herbal supplement, and citalopram, a standard antidepressant, compared to placebo.
- Placebo, Antidepressant May Lift Depression Via Common Mechanism
-
May 1, 2002
Press Release
Whether it’s a widely prescribed medication or a placebo, a successful treatment for depression must trigger a common pattern of brain activity changes, suggests a team of researchers funded by the National Institute of Mental Health.
- NIMH Awards Howard University $6.5 Million
-
January 25, 2002
Press Release
Howard University Hospital Department of Psychiatry in the College of Medicine (HUCM) has been awarded $6.5 million from the National Institute of Mental Health (NIMH) for a five-year project to implement and develop research studies pertaining to mood and anxiety disorders.